Home › Therapeutic areas › Cardiovascular › Hypoplastic Left Heart Syndrome
Hypoplastic Left Heart Syndrome (1 companies)
Companies with an active program in Hypoplastic Left Heart Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LGVN | Longeveron | CardiovascularMetabolic+1 Rare | 1 | Phase 2 | $5.8M | 4 |
No companies match.